Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The α-adrenoreceptors (alpha-adrenergic receptors) are a class of G protein-coupled receptors (GPCRs) that respond to catecholamines, primarily norepinephrine and epinephrine. They play key roles in the sympathetic nervous system, mediating physiological responses such as vasoconstriction, neurotransmitter release modulation, and smooth muscle contraction. There are two main types: α1 and α2 adrenoreceptors, each with subtypes (α1A, α1B, α1D and α2A, α2B, α2C respectively). α₁-receptors couple to the Gq protein, increasing intracellular Ca²⁺ leading to smooth muscle contraction, while α₂-receptors couple to the Gi protein, decreasing cAMP levels and inhibiting neurotransmitter release. Blockade or stimulation of these receptors underlies many therapeutic strategies targeting cardiovascular diseases, psychiatric disorders, pain management, and urological conditions.
Alpha₁: Gq → ↑Ca²⁺ → Contraction Alpha₂: Gi → ↓cAMP → Inhibition
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-Adrenoreceptor.